111 related articles for article (PubMed ID: 6672672)
1. [Serum haptoglobins in hepatic cirrhosis with portal hypertension and secondary hypersplenism].
Vai C; Santese R; Andreuzzi B; Gelosa F; Rotondo F
Minerva Dietol Gastroenterol; 1983; 29(4):313-6. PubMed ID: 6672672
[No Abstract] [Full Text] [Related]
2. Haptoglobin in splenomegalic cirrhosis; report of 40 patients after shunts and or splenectomy.
Andreuzzi P; Vai C; Santese R; Andreuzzi B; Cantoni L
Panminerva Med; 1983; 25(2):99-104. PubMed ID: 6646799
[No Abstract] [Full Text] [Related]
3. [Study of glucose tolerance tests by the continuous automatic recording method. II. Study of hyperglycemia induced by intravenous glucose injection].
Azerad E; Duprey J
Pathol Biol; 1967 May; 15(9):488-92. PubMed ID: 4864907
[No Abstract] [Full Text] [Related]
4. [Spleno-renal distal and proximal shunts for hypersplenism due to hepatic cirrhosis].
Bancu S; Borz C; Popescu G; Torok A; Mureşan A; Bancu L; Turcu M
Chirurgia (Bucur); 2007; 102(6):665-8. PubMed ID: 18323228
[TBL] [Abstract][Full Text] [Related]
5. Could serum haptoglobin concentration be used as a marker of hypersplenism in chronic liver disease?
Ozatli D; Büyükaşik Y; Haznedaroğlu IC; Koç H; Koşar A; Simşek H
Am J Gastroenterol; 1998 Dec; 93(12):2641-2. PubMed ID: 9860465
[No Abstract] [Full Text] [Related]
6. [Hypersplenism in children with extrahepatic form of portal hypertension].
Generalov AI; Leont'ev AF; Osipov IuN; Peterson IS; Kalendarev AG
Vopr Okhr Materin Det; 1975 Mar; 20(3):15-9. PubMed ID: 1121767
[No Abstract] [Full Text] [Related]
7. Estrogens and portal hypertension in cirrhosis of the liver.
Gluud C; Henriksen HH; Svenstrup B
N Engl J Med; 1981 Jan; 304(1):52. PubMed ID: 7432439
[No Abstract] [Full Text] [Related]
8. [Pathogenesis of the cytopenia syndrome in patients with cirrhosis of the liver complicated by portal hypertension].
Eramishantsev AK; Korshunov IB; Belokrinitskiĭ DV; Dudkina LN; Dem'ianov AI
Khirurgiia (Mosk); 1989 Feb; (2):36-9. PubMed ID: 2709711
[TBL] [Abstract][Full Text] [Related]
9. Serum laminin P1 levels do not reflect critically elevated portal pressure in patients with liver cirrhosis.
Bahr MJ; Böker KH; Horn W; Günzler V; Manns MP
Hepatogastroenterology; 1997; 44(16):1200-5. PubMed ID: 9261625
[TBL] [Abstract][Full Text] [Related]
10. [Implications of the arterialization of the sinusoid in its capillarization and in the maintenance of portal hypertension in the cirrhotic patient].
Ceña Lázaro G; Barrao Comps F; Omiste Martínez JL; Ducóns García J; Rojo Puente S; Laquidaín Hergueta M; Bueno Gómez J
Rev Esp Enferm Apar Dig; 1987 Feb; 71(2):111-3. PubMed ID: 3563042
[No Abstract] [Full Text] [Related]
11. [Free amino acids in the serum of portal hypertension patients].
Kataeva GA; Eremenko VP
Vestn Khir Im I I Grek; 1971 Apr; 106(4):10-4. PubMed ID: 5565362
[No Abstract] [Full Text] [Related]
12. [Serum adrenaline and noradrenaline levels in cirrhosis patients with portal hypertension].
Zhu J; Du R; Leng X
Zhonghua Wai Ke Za Zhi; 1996 Mar; 34(3):144-6. PubMed ID: 9387666
[TBL] [Abstract][Full Text] [Related]
13. [Bone marrow function test in patients with chronic liver diseases. A contribution to the problem of hypersplenism].
Weinreich J
Acta Hepatosplenol; 1969; 16(1):18-24. PubMed ID: 5800605
[No Abstract] [Full Text] [Related]
14. [Iron metabolism in patients with portal hypertension].
Gordeev PS; Eramishantsev AK; Vinnitskiĭ LI
Khirurgiia (Mosk); 1996; (1):33-6. PubMed ID: 8683916
[TBL] [Abstract][Full Text] [Related]
15. Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations.
Iwasaki Y; Sato H; Ohkubo A; Sanjo T; Futagawa S; Sugiura M; Tsuji S
Gastroenterology; 1980 Apr; 78(4):677-83. PubMed ID: 6986317
[TBL] [Abstract][Full Text] [Related]
16. [Functional activity of the thrombocytes under conditions of hypersplenism and portal hypertension in liver cirrhosis].
Makarevich IaA; Kosterova VV; Podobedov GM; Shamshev VM
Ter Arkh; 1976; 48(3):15-9. PubMed ID: 1006533
[No Abstract] [Full Text] [Related]
17. Long-term effects of distal splenorenal shunt with splenopancreatic and gastric disconnection on hypersplenism due to liver cirrhosis.
Miura H; Kondo S; Shimada T; Sugiura H; Morikawa T; Okushiba S; Katoh H
Hepatogastroenterology; 1999; 46(29):2995-8. PubMed ID: 10576390
[TBL] [Abstract][Full Text] [Related]
18. [Plasma prostacyclin (PGI2) levels in peripheral venous, arterial and portal venous blood in cirrhotic patients with portal hypertension and their clinical implication].
Yin J; Leng X; Zhu J
Zhonghua Wai Ke Za Zhi; 1995 Sep; 33(9):563-5. PubMed ID: 8731881
[TBL] [Abstract][Full Text] [Related]
19. Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients.
Alvarez OA; Lopera GA; Patel V; Encarnacion CE; Palmaz JC; Lee M
Am J Gastroenterol; 1996 Jan; 91(1):134-7. PubMed ID: 8561113
[TBL] [Abstract][Full Text] [Related]
20. Plasma amino acid patterns in portal hypertensive patients.
Wang MW; Lee XY; Lee H; Sun HK
J Gastroenterol Hepatol; 1989; 4 Suppl 1():259-61. PubMed ID: 2562391
[No Abstract] [Full Text] [Related]
[Next] [New Search]
